Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Psychopharmacology (Oxford, England)|May 17, 2018
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosisPatricia Gassó, Sergi Mas, Miquel Bioque, et al.
Schizophrenia Research|February 1, 2020
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs studyClemente García-Rizo, Miquel Bioque, Gisela Mezquida, et al.
Schizophrenia Research|February 10, 2017
Modelling gene-environment interaction in first episodes of psychosisMiguel Bernardo, Miquel Bioque, Bibiana Cabrera, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 9, 2017
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patientsSergi Mas, Patricia Gassó, Mercé Torra, et al.
Acta Psychiatrica Scandinavica|March 13, 2023
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosisIsabel Valli, Alex Gonzalez Segura, Norma Verdolini, et al.
Schizophrenia Bulletin|July 25, 2022
Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up StudyMiquel Bioque, Ana Catarina Matias-Martins, Vicent Llorca-Bofí, et al.
Psychiatry Research|May 13, 2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohortAlex G Segura, Anna Mané, Llucia Prohens, et al.
The International Journal of Neuropsychopharmacology|October 29, 2015
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs ProjectMiquel Bioque, Adrián Llerena, Bibiana Cabrera, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Psychological Medicine|June 9, 2022
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episodeAlex G Segura, Gisela Mezquida, Albert Martínez-Pinteño, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Psychopharmacology (Oxford, England)|May 17, 2018
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosisPatricia Gassó, Sergi Mas, Miquel Bioque, et al.
Schizophrenia Research|February 1, 2020
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs studyClemente García-Rizo, Miquel Bioque, Gisela Mezquida, et al.
Schizophrenia Research|February 10, 2017
Modelling gene-environment interaction in first episodes of psychosisMiguel Bernardo, Miquel Bioque, Bibiana Cabrera, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 9, 2017
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patientsSergi Mas, Patricia Gassó, Mercé Torra, et al.
Acta Psychiatrica Scandinavica|March 13, 2023
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosisIsabel Valli, Alex Gonzalez Segura, Norma Verdolini, et al.
Schizophrenia Bulletin|July 25, 2022
Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up StudyMiquel Bioque, Ana Catarina Matias-Martins, Vicent Llorca-Bofí, et al.
Psychiatry Research|May 13, 2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohortAlex G Segura, Anna Mané, Llucia Prohens, et al.
The International Journal of Neuropsychopharmacology|October 29, 2015
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs ProjectMiquel Bioque, Adrián Llerena, Bibiana Cabrera, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Psychological Medicine|June 9, 2022
Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episodeAlex G Segura, Gisela Mezquida, Albert Martínez-Pinteño, et al.
Pageof 11